Načítá se...
Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan
Background Since the launch of imatinib, chronic myeloid leukaemia has become a chronic condition requiring costly long-term treatment. Emerging evidence from several short-term studies has raised concerns on the detrimental clinical outcomes and waste of resources associated with poor adherence to...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3890042/ https://ncbi.nlm.nih.gov/pubmed/24242992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-013-9876-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|